Trends in Cancer

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Trends in Cancer
Dec 30, 2024, 11:19 | Insight
Anirban Maitra: An Open Access review on current status of KRAS inhibitors, resistance drivers and potential combinations
Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center,…
Nov 22, 2024, 12:36 | Insight
Regulating the Hippo pathway with the New class of TEAD small molecule inhibitors
Anirban Maitra shared a post on X: "And right on cue! Preprint from Genentech on a…
Nov 12, 2024, 19:13 | Insight
Anirban Maitra: Targeting the Hippo pathway in cancer by Anwesha Dey and colleagues
Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center,…
Oct 4, 2024, 09:19 | Blog
Lorenzo Galluzzi: The prognostic value of atypical B cells in breast cancer
Lorenzo Galluzzi posted on X about recent paper by him as co-author, titled "Prognostic value…
Sep 23, 2024, 13:26 | Blog
Oliver Bogler: Exploring scientific publishing as a career path for cancer scientists Montserrat Rojo de la Vega and Cansu Cirzi
Oliver Bogler shared on LinkedIn: ''On today's episode of Inside Cancer Careers we explore scientific…
Sep 10, 2024, 06:51 | Blog
Lorenzo Galluzzi: Our recent piece on cancer CSCs and immunity
Lorenzo Galluzzi posted on X about recent paper by him as co-author, titled "Epigenetic control…
Sep 2, 2024, 08:43 | Insight
Lewis Au: Preclinical and clinical developments of Bispecific Antibodies
Lewis Au, GU and GI Medical Oncologist at Peter Mac Cancer Centre, shared a post…
Jul 7, 2024, 10:05 | Insight
Murali Janakiram: Targeting cancer stem cells in multiple myeloma
Murali Janakiram, Associate Professor in the Department of Hematology and Hematopoietic Cell Transplantation at City…
Jun 21, 2024, 09:18 | Insight
Darren Haywood: Reconceptualizing mental health in cancer survivorship
Recently published in Trends in Cancer (IF = 18.4), led by Dr. Darren Haywood with an interdisciplinary and international…
Jun 15, 2024, 05:25 | Blog
Leora Horn: An update on our recent review published in Trends in Cancer
Leora Horn, Head of Clinical Development, Late Oncology at AstraZeneca, shared a post on LinkedIn: "Together…
May 2, 2024, 02:08 | Blog
Variant allele frequency by Vivek Subbiah
Vivek Subbiah shared on X: "Variant allele frequency: a decision-making tool in precision oncology? Trends…
Dec 7, 2023, 19:14 | Blog
Vivek Subbiah: Delighted to meet with the rising young oncology star from Brazil, Juliana Beal!
Vivek Subbiah shared a post on his X/Twitter page: "Such a delight to meet with…
Aug 17, 2023, 16:27 | Insight
Arndt Vogel: Excellent review, many open questions, Targeting cancers with KRAS-G12D mutations.
Arndt Vogel has recently shared 0n Twitter: ''Next batter up! Targeting cancers with KRAS-G12D mutations…
Jul 31, 2023, 17:58 | Blog
Can only movies come in sequels? Academic Papers can too! - Vivek Subbiah
Can only movies come in sequels? Academic Papers can too!   Excited to introduce the…
Jul 31, 2023, 17:24 | Drugs
Delighted to share our latest paper on "Tumor-agnostic drug development in dMMR/MSI-H solid tumors" just published in Trends in Cancer - Vivek Subbiah
Hot off the press! Weekend Reading.  :arrow: Delighted to share our latest paper on "Tumor-agnostic…
All: 15 Posts: 1 - 100
Special Coverage